[go: up one dir, main page]

ITMI932612A1 - Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono - Google Patents

Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono

Info

Publication number
ITMI932612A1
ITMI932612A1 IT002612A ITMI932612A ITMI932612A1 IT MI932612 A1 ITMI932612 A1 IT MI932612A1 IT 002612 A IT002612 A IT 002612A IT MI932612 A ITMI932612 A IT MI932612A IT MI932612 A1 ITMI932612 A1 IT MI932612A1
Authority
IT
Italy
Prior art keywords
salts
contain
fatty acid
pharmaceutical formulations
polyunsaturated fatty
Prior art date
Application number
IT002612A
Other languages
English (en)
Inventor
Tiberio Bruzzese
Original Assignee
Prospa Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prospa Bv filed Critical Prospa Bv
Publication of ITMI932612A0 publication Critical patent/ITMI932612A0/it
Priority to IT93MI002612A priority Critical patent/IT1264987B1/it
Priority to DE69409969T priority patent/DE69409969T2/de
Priority to JP7516492A priority patent/JPH09508619A/ja
Priority to AU12412/95A priority patent/AU1241295A/en
Priority to US08/649,707 priority patent/US5750572A/en
Priority to EP95903298A priority patent/EP0734373B1/en
Priority to PCT/EP1994/003943 priority patent/WO1995016661A1/en
Priority to ES95903298T priority patent/ES2117390T3/es
Publication of ITMI932612A1 publication Critical patent/ITMI932612A1/it
Application granted granted Critical
Publication of IT1264987B1 publication Critical patent/IT1264987B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/16—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT93MI002612A 1993-12-14 1993-12-14 Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono IT1264987B1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT93MI002612A IT1264987B1 (it) 1993-12-14 1993-12-14 Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
US08/649,707 US5750572A (en) 1993-12-14 1994-11-28 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
JP7516492A JPH09508619A (ja) 1993-12-14 1994-11-28 ポリ不飽和脂肪酸の塩とこれらを含む医薬製剤
AU12412/95A AU1241295A (en) 1993-12-14 1994-11-28 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
DE69409969T DE69409969T2 (de) 1993-12-14 1994-11-28 Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
EP95903298A EP0734373B1 (en) 1993-12-14 1994-11-28 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
PCT/EP1994/003943 WO1995016661A1 (en) 1993-12-14 1994-11-28 Salts of a polyunsaturated fatty acid and pharmaceutical formulations containing them
ES95903298T ES2117390T3 (es) 1993-12-14 1994-11-28 Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI002612A IT1264987B1 (it) 1993-12-14 1993-12-14 Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono

Publications (3)

Publication Number Publication Date
ITMI932612A0 ITMI932612A0 (it) 1993-12-14
ITMI932612A1 true ITMI932612A1 (it) 1995-06-14
IT1264987B1 IT1264987B1 (it) 1996-10-17

Family

ID=11367322

Family Applications (1)

Application Number Title Priority Date Filing Date
IT93MI002612A IT1264987B1 (it) 1993-12-14 1993-12-14 Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono

Country Status (8)

Country Link
US (1) US5750572A (it)
EP (1) EP0734373B1 (it)
JP (1) JPH09508619A (it)
AU (1) AU1241295A (it)
DE (1) DE69409969T2 (it)
ES (1) ES2117390T3 (it)
IT (1) IT1264987B1 (it)
WO (1) WO1995016661A1 (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
AUPM906594A0 (en) * 1994-10-26 1994-11-17 Peptide Technology Limited Synthetic polyunsaturated fatty acid analogues
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
FR2781371B1 (fr) 1998-07-21 2001-04-27 Oreal Composition cosmetique aqueuse transparente a une seule phase
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
EP1423107B1 (en) * 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Fatty alcohol drug conjugates
EP1427407A4 (en) 2001-03-23 2005-05-11 Luitpold Pharm Inc FAT AMIN DRUG CONJUGATES
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
JP2003261456A (ja) * 2002-03-08 2003-09-16 Howaizu:Kk 脳の老化予防剤
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
US20050130937A1 (en) * 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US8052992B2 (en) * 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
HU227588B1 (hu) * 2004-12-03 2011-09-28 Sinnex Mueszaki Fejlesztoe Es Tanacsado Kft Többszörösen telítetlen zsírsavak észtereit tartalmazó vírusellenes és immunstimuláns gyógyászati készítmény
ITMI20072142A1 (it) * 2007-11-08 2009-05-09 Yervant Zarmanian Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3
EP2224930B1 (en) 2008-01-04 2016-06-15 Nestec S.A. Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions
WO2010068173A1 (en) 2008-12-12 2010-06-17 Daniel Klamer L-lysine for improving normal cognitive functions
KR102153245B1 (ko) 2012-01-06 2020-09-08 옴테라 파마슈티칼스, 인크. 유리 산 형태의 오메가-3 다중불포화 지방산의 ｄｐａ-농축 조성물
MX2016016830A (es) * 2014-06-18 2017-07-07 Thetis Pharmaceuticals Llc Complejos de aminoacidos minerales de agentes activos.
RU2706072C2 (ru) * 2014-12-23 2019-11-13 Эвоник Дегусса Гмбх Способ повышения устойчивости композиции, содержащей омега-6 полиненасыщенные жирные кислоты
JP6861156B2 (ja) 2014-12-23 2021-04-21 エボニック オペレーションズ ゲーエムベーハー ω−３系多価不飽和脂肪酸を含む組成物の安定性を向上させる方法
FR3031451B1 (fr) * 2015-01-13 2018-03-23 Greentech Sel d'un triglyceride, preparation et utilisations
EP3248467A1 (de) * 2016-05-25 2017-11-29 Evonik Technochemie GmbH Verfahren zur herstellung einer zusammensetzung enthaltend omega-3-fettsäure-l-lysin-salze
WO2017202942A1 (en) * 2016-05-25 2017-11-30 Evonik Technochemie Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
DK3454907T3 (da) 2016-06-03 2020-10-19 Thetis Pharmaceuticals Llc Sammensætninger og fremgangsmåder relateret til salte af specialiserede pro-løsningsmediatorer af inflammation
WO2019008101A1 (en) 2017-07-06 2019-01-10 Evonik Technochemie Gmbh ENTERICALLY COATED SOLID DOSAGE FORM COMPRISING AMINO ACIDS SALTS OF OMEGA-3 FATTY ACIDS
CA3072658C (en) * 2017-08-15 2023-01-24 Evonik Operations Gmbh Tablets with high active ingredient content of omega-3 fatty acid amino acid salts
WO2019093708A1 (ko) * 2017-11-08 2019-05-16 김승수 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
KR102172036B1 (ko) * 2017-11-08 2020-10-30 주식회사 오스테온 악취 억제형 불포화오일 및 아르기닌 함유 조성물의 제조 방법
JP7438216B2 (ja) * 2018-11-30 2024-02-26 エボニック オペレーションズ ゲーエムベーハー リン脂質と脂肪酸塩の分散体を含む調製物
WO2020225068A1 (en) 2019-05-06 2020-11-12 Evonik Operations Gmbh Preparation for use in weight management comprising omega-3 fatty acid salts and basic amino acids
US20220211732A1 (en) * 2019-05-23 2022-07-07 Evonik Operations Gmbh Prebiotic compositions
ES3038193T3 (en) 2019-08-08 2025-10-10 Evonik Operations Gmbh Method of preparing a solid dosage form and a binder
EP3804699A1 (en) 2019-10-10 2021-04-14 Evonik Operations GmbH Method of preparing a solid dosage form and a binder
EP4009961A1 (en) 2019-08-08 2022-06-15 Evonik Operations GmbH Solubility enhancement of poorly soluble actives
JP7569838B2 (ja) 2019-08-08 2024-10-18 エボニック オペレーションズ ゲーエムベーハー 多価不飽和脂肪酸塩を製造するための下流処理
AU2020324553B2 (en) 2019-08-08 2025-10-23 Evonik Operations Gmbh Method of preparing a solid dosage form and a lubricant
CA3168635A1 (en) * 2020-01-30 2021-08-05 Silicycle Inc. Process for preparing a solid form of basic amino acid salts of polyunsaturated fatty acids
EP4125437A1 (en) 2020-04-01 2023-02-08 Evonik Operations GmbH Preparation for use as vasorelaxant
WO2021197971A1 (en) 2020-04-01 2021-10-07 Evonik Operations Gmbh Preparation for use as antioxidant
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3952035A (en) * 1973-04-25 1976-04-20 Sandoz Ltd., (Sandoz Ag) Organic compounds
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production

Also Published As

Publication number Publication date
JPH09508619A (ja) 1997-09-02
EP0734373A1 (en) 1996-10-02
IT1264987B1 (it) 1996-10-17
ES2117390T3 (es) 1998-08-01
DE69409969D1 (de) 1998-06-04
AU1241295A (en) 1995-07-03
US5750572A (en) 1998-05-12
WO1995016661A1 (en) 1995-06-22
ITMI932612A0 (it) 1993-12-14
EP0734373B1 (en) 1998-04-29
DE69409969T2 (de) 1998-12-10

Similar Documents

Publication Publication Date Title
ITMI932612A1 (it) Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono
PT0900782E (pt) Ester do acido 2-cianacrilico
ZA929147B (en) Fatty acid esters of alkoxylated isethionic acid
DK0900260T3 (da) Kvaternær ammoniumforbindelse med højt indhold af dialkylfedtsyreester af trialkanolamin
IL102901A (en) Pharmaceutical compositions comprising oleic acid r C1 to C4 alkyl ester thereof a C2-C4 fatty acid and an acetylcholinesterase inhibitor of the carbamate type
NZ219973A (en) Topical antimicrobial pharmaceutical compositions containing ethoxylated or propoxylated glyceryl fatty acid esters
IL103932A (en) Fatty acid and pharmaceutical compositions containing them
SI1216048T1 (en) Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
EE9700281A (et) Rasvhapete estrid kui bioaktiivsed ühendid
ZA945189B (en) Sulfonation of fatty acid esters
IL105700A0 (en) Pharmaceutical compositions containing a retinoic acid or a salt or ester thereof and a vitamin d derivative
FI923357A7 (fi) Rasvahappolääkkeiden valmistus
DE69302098D1 (de) Zusammensetzungen von hexitan-fettsäureestern
AU2111095A (en) Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them
IL78528A0 (en) Difluoro-naphthyridine-and trifluoro-quinoline-carboxylic acids and esters and salts thereof and pharmaceutical compositions containing them
PT80272B (pt) Processo para a preparacao de amidas e esteres de acidos dihidropiridinil-dicarboxilicos terapeuticamente activos e de composicoes farmaceuticas que os contem
EP0596284A3 (de) Antimycotische kosmetische und dermatologische Zubereitungen mit einem Gehalt an Fettsäureestern.
SI1399152T1 (sl) Farmacevtski sestavek, ki obsega inhibitor lipaze in monoester saharoze z maĺ äśobno kislino
DK0718275T3 (da) Kvaternære triethanolaminfedtsyreestere
DE59305938D1 (de) Pyridyloxy-acrylsäureester
HU9302150D0 (en) Oplant protecting preparatives containing substituted acrylic acid esters and method for producing said active substance
NZ215587A (en) 3-oxoandrost-4-ene-17beta-carboxylic acid ester derivatives and pharmaceutical compositions
PL333247A1 (en) Method of manufacturing of salts and esters of clavulan acid
ITMI922792A0 (it) Sali di acidi poliinsaturi omega-3 e formulazioni farmaceutiche che li contengono
IT9019184A0 (it) Derivato otticamente attivo dell'acido d-2-(6-metossi-2-naftil)- propionico e composizioni farmaceutiche che lo contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971223